TERN

Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review

04/07 02:28 pm

What's Going On With Merck Stock Tuesday?

04/07 12:46 pm

Merck Just Made a Big Bet on a New Cancer Growth Engine

04/02 11:32 am

Merck Locks Infinimmune Alliance To Chase Next-Gen Antibody Drugs

04/01 09:26 am

Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst

03/25 11:20 am

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

03/25 06:48 am

Merck Nears $6 Billion Deal To Buy Terns Pharma: Report

03/25 05:38 am

This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally

03/16 08:00 pm

ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing

02/20 01:02 am

Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge

02/17 01:32 pm

Terns Announces Pricing of Upsized $650 Million Public Offering

12/10 12:30 am

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting

12/08 03:45 pm

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors

12/03 10:11 am

This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

09/18 10:07 am

Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

09/15 07:21 am

Should You Invest in This Under-the-Radar Weight Loss Stock?

09/15 06:09 am

1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More

09/14 10:12 am

Terns Announces Pricing of Upsized $150.15 Million Public Offering

09/10 10:50 pm

Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs? - The Motley Fool

07/20 09:30 am

Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation

06/21 06:30 pm

Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?

06/19 01:27 pm

Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's is How to Trade

06/04 09:55 am

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

06/03 04:10 pm

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

05/30 08:05 am

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day

05/17 04:05 pm

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates

05/13 08:05 am

Terns Pharmaceuticals Announces Leadership Changes

05/08 04:05 pm

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

05/03 04:05 pm

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation

04/29 04:05 pm

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

04/10 04:05 pm

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

03/17 05:50 am

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

03/14 04:05 pm

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

03/11 04:05 pm

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

03/07 05:05 pm

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

02/27 05:05 pm

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

02/09 02:18 pm

Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)

02/07 05:05 pm

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

02/07 09:05 am

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

02/02 05:05 pm

Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

01/04 05:05 pm

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

01/03 05:05 pm

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs

12/05 10:05 am

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session

12/04 02:10 pm

SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday

12/04 11:33 am

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

11/29 05:05 pm

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer

11/27 05:05 pm

Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Updates

11/14 09:05 am

Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023

11/13 09:05 am

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences

11/09 09:05 am

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

11/03 04:05 pm